The Scan That Finds Everything Except What Will Kill You
Walk into any corporate diagnostic centre in Mumbai, Bengaluru, or Delhi and you will find a "Full Body Scan" package priced between ₹8,000 and ₹40,000. It typically includes a whole-body CT or PET-CT, a battery of blood panels, and a chest X-ray. The marketing language promises "complete peace of mind." What it delivers, more often than not, is a list of incidental findings, a cyst on the liver, a small nodule on the thyroid, a shadow near the adrenal gland, that are almost certainly benign but now require follow-up scans, specialist consultations, and, in some cases, biopsies. A 2022 analysis published in the journal Radiology estimated that whole-body CT screening in asymptomatic individuals produces incidental findings in up to 86% of scans, with the vast majority having no clinical significance. The patient leaves not reassured but anxious, and the diagnostic clock starts ticking on a problem that was never a problem.
What the Evidence Actually Says About Preventive Screening
The screenings with the strongest evidence behind them are unglamorous and cheap. A Pap smear, which costs under ₹300 at most government hospitals, detects precancerous cervical changes years before they become cancer. Cervical cancer kills approximately 77,000 Indian women every year, according to ICMR data, and it is almost entirely preventable with regular screening. Yet coverage remains below 30% in most states. Colorectal cancer screening with a fecal occult blood test costs roughly ₹200 and catches the disease at a stage when survival rates exceed 90%. Diabetic retinopathy screening, a dilated eye exam, costs almost nothing at a district hospital and prevents the leading cause of preventable blindness in India. None of these tests produce a dramatic scan image. None of them come in a corporate folder with your name embossed on it. That is precisely why they are skipped.
Why Overdiagnosis Is a Medical Problem, Not Just a Financial One
The term overdiagnosis refers to the detection of a condition that would never have caused symptoms or death. It is not a fringe concern. A 2019 paper in the BMJ estimated that overdiagnosis from low-value screening costs health systems globally hundreds of billions of dollars annually and causes direct patient harm through unnecessary procedures. In India, the problem is compounded by a fee-for-service diagnostic model where labs and hospitals profit from each downstream test a scan generates. A thyroid nodule found incidentally on a full-body CT leads to an ultrasound, which leads to a fine-needle aspiration, which leads to a surgery that removes a thyroid that was functioning normally. The patient is now on lifelong hormone replacement for a cancer that posed no threat. This is not hypothetical. Thyroid cancer incidence in India has risen sharply, driven largely by incidental detection rather than a genuine increase in disease burden, according to a 2021 review in the Indian Journal of Endocrinology and Metabolism.
The Checkup Indians Should Actually Be Getting
Evidence-based preventive care is age- and risk-stratified, not a flat scan of everything. For adults over 40 with no family history, the priority list looks like this: blood pressure measurement (free at any PHC), fasting blood glucose and HbA1c for diabetes risk, a lipid panel, Pap smear for women every three to five years, and a clinical breast exam. For smokers, a low-dose CT of the chest is genuinely recommended, but only for high-risk individuals, not as a general wellness product. Colonoscopy is appropriate from age 45 onward for average-risk individuals. Hepatitis B and C testing matters in India given the prevalence. None of this requires a premium diagnostic package. The ICMR's National Cancer Grid has published screening guidelines that align closely with global evidence, and they do not include whole-body CT for asymptomatic adults.
The diagnostic industry has successfully conflated two different things: the desire for reassurance and the practice of preventive medicine. A full-body scan satisfies the first while frequently undermining the second. The tests that actually reduce mortality are the ones that require a referral, a follow-up, and sometimes an uncomfortable conversation with a doctor, not a glossy report handed over at a reception desk.
